DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 2.86% to $781.60 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.83% to 6,795.99 and the Dow Jones Industrial Average rising 0.50% to 47,740.80.
The stock's rise snapped a two-day losing streak.
Regeneron Pharmaceuticals Inc. closed 4.81% short of its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 2.01% to $376.97, Moderna Inc. (MRNA) rose 6.13% to $55.74, and Gilead Sciences Inc. (GILD) rose 1.88% to $146.63.
Trading volume (696,775) remained 78,147 below its 50-day average volume of 774,922.
Data source: Dow Jones Market Data, FactSet. Data compiled March 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 09, 2026 16:42 ET (20:42 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments